Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for stable chronic obstructive pulmonary disease
about
Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for stable chronic obstructive pulmonary disease
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@ast
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@en
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@nl
type
label
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@ast
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@en
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@nl
prefLabel
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@ast
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@en
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@nl
P2093
P2860
P1476
Long-acting muscarinic antagon ...... obstructive pulmonary disease
@en
P2093
Kenjiro Nagai
Kentaro Nakashima
Nobuyuki Horita
Takeshi Kaneko
P2860
P356
10.1002/14651858.CD012066
P577
2016-02-02T00:00:00Z